Nasra H. Giama, DNP, RN, PHN

Clinical Associate Professor and Assistant Director of Inclusivity, Diversity, & Equity Committee, School of Nursing

Nasra H. Giama

Contact Info

giama003@umn.edu

Office Phone 507-258-8041

Office Address:
Rochester Campus
390F University Square

Mailing Address:
300 University Square
111 South Broadway
Rochester, MN 55904

Clinical Associate Professor and Assistant Director of Inclusivity, Diversity, & Equity Committee, School of Nursing

Assistant Director of Inclusivity, Diversity, & Equity Committee, School of Nursing


Summary

Dr. Giama is a public health nurse interested in the intersection of health education and culture with a primary emphasis on health promotion and prevention in immigrant populations and adolescents. Dr. Giama is clinical associate professor in the University of Minnesota School of Nursing and an assistant professor of medicine at Mayo Clinic. Dr. Giama provides professional, scholarly leadership in four primary areas: (1) health promotion and prevention, (2) scholarship focused on methods to promote the health and well-being of immigrant and refugee communities through community engagement strategies (3) transforming health equity and social justice in nursing education, (4) mentorship for diverse students in healthcare. 

Awards & Recognition

  • Internationalizing Teaching and Learning Faculty Cohort Program, 2018-2020
  • Faculty Diversity and Inclusivity Award, 2015
  • Leadership Education in Adolescent Health (LEAH) Fellowship, 2012-2013
  • Alva Wipperman Queneau Scholarship, 2010-2011
  • Excellence Through Teamwork Recipient, Mayo Clinic, 2012

Professional Associations


Research

Research Summary/Interests

My funded projects and publications are focused around disparities in health related to liver cancer, viral hepatitis, and developing interventions to deliver culturally and linguistically tailored care to immigrant communities a s well as coordination national and international studies on the early detection and prevention of liver and bile duct cancers. Additionally, my community health funded projects aim to promote the educational attainment of minority students as well as implementing coalition building interventions to increase community capacity. 

Publications

Peer-reviewed articles

  • Shire AM, Sandhu DS, Kaiya JK, Oseini AM, Yang JD, Chaiteerakij R, Mettler TA, Giama NH, Roberts RO, Therneau TM, Petersen GM, Knutson KL, Roberts LR. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clin Proc. 2012 Jan; 87 (1):17-24 PMID: 22212964 PMCID: 3337857 DOI: 10.1016/j.mayocp.2011.08.001
  • Bhat M, Chaiteerakij R, Harmsen WS, Schleck CD, Yang JD, Giama NH, Therneau TM, Gores GJ, Roberts LR. Metformin does not improve survival in patients with hepatocellular carcinoma. World J Gastroenterol. 2014 Nov 14; 20: (42)15750-5. PMID: 25400459 PMCID: 4229540 DOI: 10.3748/wjg.v20.i42.15750
  • Chaiteerakij R, Zhang X, Addissie BD, Mohamed EA, Harmsen WS, Theobald PJ, Peters BE, Balsanek JG, Ward MM, Giama NH, Moser CD, Oseini AM, Umeda N, Venkatesh S, Harnois DM, Charlton MR, Yamada H, Satomura S, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015 May; 21: (5)599-606. PMID: 25789635 PMCID: 4490162 DOI: 10.1002/lt.24117
  • Chaiteerakij R, Juran BD, Aboelsoud MM, Harmsen WS, Moser CD, Giama NH, Allotey LK, Mettler TA, Baichoo E, Zhang X, Therneau TM, Lazaridis KN, Roberts LR. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma. Cancer Med. 2015 Oct; 4: (10)1599-602. PMID: 26276523 PMCID: 4618630 DOI: 10.1002/cam4.501
  • Yang JD, Campion MB, Liu MC, Chaiteerakij R, Giama NH, Ahmed Mohammed H, Zhang X, Hu C, Campion VL, Jen J, Venkatesh SK, Halling KC, Kipp BR, Roberts LR. Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma. Hepatology. 2016 Jan; 63: (1)148-58. PMID: 26096702 PMCID: 4684812 DOI: 10.1002/hep.27944
  • Blackburn PR, Hickey RD, Nace RA, Giama NH, Kraft DL, Bordner AJ, Chaiteerakij R, McCormick JB, Radulovic M, Graham RP, Torbenson MS, Tortorelli S, Scott CR, Lindor NM, Milliner DS, Oglesbee D, Al-Qabandi W, Grompe M, Gavrilov DK, El-Youssef M, Clark KJ, Atwal PS, Roberts LR, Klee EW, Ekker SC. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma. Hum Mutat. 2016 Oct; 37 (10):1097-105 Epub 2016 Aug 08 PMID: 27397503 PMCID: 5108417 DOI: 10.1002/humu.23047
  • Ahmed Mohammed HA, Yang JD, Giama NH, Choi J, Ali HM, Mara KC, Harmsen WS, Wiesner RH, Leise MD, Therneau TM, Roberts LR. Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis. Liver Cancer. 2017 Feb; 6 (2):126-136 Epub 2016 Dec 17 PMID: 28275579 PMCID: 5340216 DOI: 10.1159/000450833
  • Elraiyah T, Jerde CR, Shrestha S, Wu R, Nie Q, Giama NH, Sarangi V, Roberts LR, Offer SM, Diasio RB. Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5-Fluorouracil Sensitivity in an East African Population. Clin Pharmacol Ther. 2017 Mar; 101: (3)382-390. PMID: 27727460 PMCID: 5309195 DOI: 10.1002/cpt.531
  • Betesh L, Comunale MA, Wang M, Liang H, Hafner J, Karabudak A, Giama NH, Moser CD, Miyoshi E, Roberts LR, Block TM, Mehta A. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma. Proteomics Clin Appl. 2017 Sep; 11 (9-10) Epub 2017 July 10 PMID: 28561948 DOI: 10.1002/prca.201600141
  • Jun TW, Yeh ML, Yang JD, Chen VL, Nguyen P, Giama NH, Huang CF, Hsing AW, Dai CY, Huang JF, Chuang WL, Roberts LR, Yu ML, Nguyen MH. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Liver Int. 2017 Oct 16 [Epub ahead of print] PMID: 29045023 DOI: 10.1111/liv.13613
  • Betesh L, Comunale MA, Wang M, Liang H, Hafner J, Karabudak A, Giama NH, Moser CD, Miyoshi E, Roberts LR, Block TM, Mehta A. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma. Proteomics Clin Appl. 2017 Sep; 11 (9-10) Epub 2017 July 10 PMID: 28561948 PMCID: 6014737 DOI: 10.1002/prca.201600141
  • Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol. 2018 Mar 28; 24 (12):1321-1331 PMID: 29599607 PMCID: 5871827 DOI: 10.3748/wjg.v24.i12.1321
  • Jun TW, Yeh ML, Yang JD, Chen VL, Nguyen P, Giama NH, Huang CF, Hsing AW, Dai CY, Huang JF, Chuang WL, Roberts LR, Yu ML, Nguyen MH. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Liver Int. 2018 May; 38 (5):895-902 Epub 2017 Nov 03 PMID: 29045023 DOI: 10.1111/liv.13613
  • Kisiel JB, Dukek BA, Kanipakam RVSR, Ghoz HM, Yab TC, Berger CK, Taylor WR, Foote PH, Giama NH, Onyirioha K, Abdallah MA, Burger KN, Slettedahl SW, Mahoney DW, Smyrk TC, Lewis JT, Giakoumopoulos M, Allawi HT, Lidgard G, Roberts LR, Ahlquist DA. Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation. Hepatology. 2018 Aug 31 [Epub ahead of print] PMID: 30168613 DOI: 10.1002/hep.30244
  • Li Y, Chaiteerakij R, Kwon JH, Jang JW, Lee HL, Cha S, Ding XW, Thongprayoon C, Ha FS, Nie CY, Zhang Q, Yang Z, Giama NH, Roberts LR, Han T. A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection. Medicine (Baltimore). 2018 Oct; 97 (41):e12758 PMID: 30313084 PMCID: 6203558 DOI: 10.1097/MD.0000000000012758
  • Estevez J, Yang JD, Leong J, Nguyen P, Giama NH, Zhang N, Ali HA, Lee MH, Cheung R, Roberts L, Schwartz M, Nguyen MH. Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma. Am J Gastroenterol. 2018 Oct 17 [Epub ahead of print] PMID: 30333542 DOI: 10.1038/s41395-018-0261-y
  • Yang JD, Addissie BD, Mara KC, Harmsen WS, Dai J, Zhang N, Wongjarupong N, Ali HM, Ali HA, Hassan FA, Lavu S, Cvinar JL, Giama NH, Moser CD, Miyabe K, Allotey LK, Algeciras-Schimnich A, Theobald JP, Ward MM, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Srivastava S, Rinaudo JA, Gores GJ, Feng Z, Marrero JA, Roberts LR. GALAD Score for Hepatocellular Carcinoma Detection in Comparison to Liver Ultrasound and Proposal of GALADUS Score. Cancer Epidemiol Biomarkers Prev. 2018 Nov 21 [Epub ahead of print] PMID: 30464023 DOI: 10.1158/1055-9965.EPI-18-0281
  • Elwir S, Anugwom C, Connor EK, Giama NH, Ndzengue A, Menk J, Mohamed EA, Roberts LR, Hassan M. Barriers in Hepatitis C Treatment in Somali Patients in the Direct Acting Antiviral Therapy Era. J Natl Med Assoc. 2018 Dec; 110 (6):556-559 Epub 2018 Mar 10 PMID: 30129499 DOI: 10.1016/j.jnma.2018.02.002
  • Zhang N, Jin W, Zhou S, Yang JD, Harmsen WS, Giama NH, Wongjarupong N, Heimbach JK, Watt KD, Malhi H, Therneau TM, Roberts LR. Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation. Cancer Med. 2018 Dec; 7 (12):5870-5878 Epub 2018 Nov 19 PMID: 30453389 PMCID: 6308061 DOI: 10.1002/cam4.1797
  • Hlady, R. A., Zhao, X., Pan, X., Yang, J. D., Ahmed, F., Antwi, S. O., … Robertson, K. D. (2019). Theranostics Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA, 9(24). https://doi.org/10.7150/thno.35573
  • Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., … Rinaudo, J. A. (2019). GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score, 531–539. https://doi.org/10.1158/1055-9965.EPI-18-0281